Related Experiment Video
Updated: May 21, 2026

Heteromulticellular Stromal Cells in Scaffold-free 3D Cultures of Epithelial Cancer Cells to Drive Invasion
Published on: April 4, 2025
Multifocal epithelial tumors and field cancerization from loss of mesenchymal CSL signaling
Bing Hu1, Einar Castillo, Louise Harewood
1Department of Biochemistry, University of Lausanne, Switzerland.
Abstract:
It is currently unclear whether tissue changes surrounding multifocal epithelial tumors are a cause or consequence of cancer. Here, we provide evidence that loss of mesenchymal Notch/CSL signaling causes tissue alterations, including stromal atrophy and inflammation, which precede and are potent triggers for epithelial tumors. Mice carrying a mesenchymal-specific deletion of CSL/RBP-Jκ, a key Notch effector, exhibit spontaneous multifocal keratinocyte tumors that develop after dermal atrophy and inflammation. CSL-deficient dermal fibroblasts promote increased tumor cell proliferation through upregulation of c-Jun and c-Fos expression and consequently higher levels of diffusible growth factors, inflammatory cytokines, and matrix-remodeling enzymes. In human skin samples, stromal fields adjacent to multifocal premalignant actinic keratosis lesions exhibit decreased Notch/CSL signaling and associated molecular changes. Importantly, these changes in gene expression are also induced by UVA, a known environmental cause of cutaneous field cancerization and skin cancer.
Insights
Loss of mesenchymal Notch/CSL signaling triggers skin cancer by causing tissue changes like atrophy and inflammation. This discovery offers new insights into cancer development and potential therapeutic targets for skin tumors.
Area of Science:
- Dermatology
- Molecular Biology
- Oncology
Background:
- The relationship between tissue changes and multifocal epithelial tumors remains unclear.
- Investigating the role of mesenchymal signaling in tumor initiation is crucial for understanding cancer development.
Purpose of the Study:
- To investigate whether loss of mesenchymal Notch/CSL signaling causes or results from tissue alterations preceding epithelial tumors.
- To explore the molecular mechanisms by which CSL-deficient fibroblasts promote tumor cell proliferation.
Main Methods:
- Utilizing genetically engineered mice with mesenchymal-specific deletion of CSL/RBP-Jκ.
- Analyzing dermal fibroblasts from knockout mice for changes in gene expression and growth factor secretion.
- Examining human skin samples adjacent to actinic keratosis lesions for Notch/CSL signaling alterations.
- Investigating the effects of UVA radiation on gene expression in skin samples.
Main Results:
- Mesenchymal-specific CSL/RBP-Jκ deletion in mice led to stromal atrophy and inflammation, preceding spontaneous multifocal keratinocyte tumors.
- CSL-deficient dermal fibroblasts exhibited upregulated c-Jun and c-Fos, increasing tumor cell proliferation via growth factors and inflammatory cytokines.
- Human skin adjacent to actinic keratosis showed decreased Notch/CSL signaling.
- UVA radiation induced similar gene expression changes, linking environmental factors to these molecular alterations.
Conclusions:
- Loss of mesenchymal Notch/CSL signaling is a potent trigger for epithelial tumors, initiating a cascade of tissue alterations.
- CSL-deficient fibroblasts create a tumor-promoting microenvironment through molecular signaling.
- These findings highlight the role of stromal signaling in skin cancer development and suggest potential therapeutic targets.
Related Concept Videos
The Tumor Microenvironment
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Mitogens and the Cell Cycle
Abnormal Proliferation

